Work history
David Samadi has completed his post-graduate training in general surgery at Montefiore Medical Centre and in urology at Albert Einstein School of Medicine and Montefiore Medical Centre. He also attended an oncology fellowship in urology at Memorial Sloan Kettering Cancer Centre and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France. Until now, David Samadi along with his second family, his team, has performed countless successful operations and saved precious lives and families. As an expert on robotic surgery, Dr Samadi developed his own treatment called SMART Surgery. From day one, he personally takes care of each patient as he educates and supports every step of the way.
Dr. David Samadi’s work history and practice
Director of Men's Health
Dr. David Samadi and his medical team used the latest technologies to treat urological issuess such as prostate cancer, BPH, prostatitis, erectile dysfunctionand more, at St. Francis Hospital, the Heart Center, in Roslyn, NY.
Urologic Oncology Expert and Robotic Surgeon at Lenox Hill Hospital
After having done over 7000 robotic prostate surgeries, David B Samadi has built a premier Urology program at Lenox Hill Hospital. Located in New York, this hospital is equipped with the best technology, science, top physicians and leaders that truly care about the patients. Here, Samadi performed the da Vinci prostate surgery along with his very well trained team: the staff, the nurses, and the medical assistants.
Contributor for Fox News Health
In 2011 a very interesting project became part of his career as a health trainer. David Samadi has started to be part of the Fox News Health TV program offering the latest health news and pieces of information regarding prostate cancer and surgery procedures.
Fox News Contributor
As a member of the Fox New, Dr David Samadi has focused on bringing up the most up to date discoveries and reports on the latest technology and research projects.
Fox News Medical Consultant
Dr David Samadi has been a Medical Contributor to Fox News in the last 8 years, and also a member of Medical Team Anchor on Sunday House Call every Sunday at 12:30 pm.
Chief of Robotic Surgery at Mount Sinai Medical Center
It is well known that David Samadi’s work in concerned on treating men with prostate cancer. The robotic center at Mount Sinai concentrates not only on surgical aspects of prostate cancer but also on prevention, watchful waiting and focal therapy of prostate cancer. Here, Dr David Samadi has treated each patient individually and specifically according to their needs.
Director of Laparoscopic Surgery at the Columbia Presbyterian in New York
After the first 5 years spent at the Columbia Presbyterian in New York, David Samadi has obtained the certificate of Prostate Cancer Expert.
Volunteer at the Emergency Room in Stoney Brook Hospital
Between 1990 and 1994, David Samadi has been a volunteer at the Emergency Room in Stoney Brook Hospital. During this period, Samadi has been taking care of sick patients and has been rounding with the morning team. CAUSES Dr David Samadi cares about: – Education – Environment – Health – Disaster and Humanitarian Relief
Mann about town
‘Mann about town’ is a publication about Dr David Samadi’s brief summary of his bio and work. Being one of the few urologic surgeons in the United States trained in oncology, open surgery, laparoscopic surgery and robotic surgery. The reasons why Dr David Samadi launched this publication was to draw attention to the fact that in our daily life prostate cancer is the second most commonly diagnosed cancer in men after skin cancer and it is the second leading cause of cancer death in men after lung cancer.
Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men
Dr Samadi investigated the relationships between clinic pathologic variables across racial and socioeconomic lines following robotic-assisted laparoscopic prostatectomy. Longitudinal studies report racial disparities in prostate cancer (PCa) including greater incidence, more aggressive tumor biology, and increased cancer-specific mortality in African American (AA) men. Regret concerning primary treatment selection is under evaluated in patients with PCa. The conclusions made regarding about this subject are all described in this publication.
LANGUAGES
English Persian Hebrew French